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Abstract
Background: Infection with Helicobacter pylori triggers a chronic gastric inflammation that can progress to atrophy and
gastric adenocarcinoma. Polarization of macrophages is a characteristic of both cancer and infection, and may promote
progression or resolution of disease. However, the role of macrophages and their polarization during H. pylori infection has
not been well defined.
Methodology/Principal Findings: By using a mouse model of infection and gastric biopsies from 29 individuals, we have
analyzed macrophage recruitment and polarization during H. pylori infection by flow cytometry and real-time PCR. We
found a sequential recruitment of neutrophils, eosinophils and macrophages to the gastric mucosa of infected mice. Gene
expression analysis of stomach tissue and sorted macrophages revealed that gastric macrophages were polarized to M1
after H. pylori infection, and this process was substantially accelerated by prior vaccination. Human H. pylori infection was
characterized by a mixed M1/M2 polarization of macrophages. However, in H. pylori-associated atrophic gastritis, the
expression of inducible nitric oxide synthase was markedly increased compared to uncomplicated gastritis, indicative of an
enhanced M1 macrophage polarization in this pre-malignant lesion.
Conclusions/Significance: These results show that vaccination of mice against H. pylori amplifies M1 polarization of gastric
macrophages, and that a similar enhanced M1 polarization is present in human H. pylori-induced atrophic gastritis.
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Introduction
Helicobacter pylori colonize the stomach epithelium of more than
half of the world’s population [1]. The infection is often life-long
and triggers a chronic inflammation in the gastric mucosa, which
in about 1–2% of infected individuals eventually develops into
gastric adenocarcinoma [1]. Development of gastric cancer, in
particular the intestinal type, is a multi-step process that progresses
over decades through premalignant lesions in the gastric mucosa,
such as atrophic gastritis, intestinal metaplasia, and dysplasia [2].
The outcome of the infection depends on the virulence of the
infecting H. pylori strain, environmental factors such as smoking
and diet, and host genetic factors that influence the type and
intensity of the inflammatory response [1].
A strong pro-inflammatory response is associated with increased
levels of reactive oxygen and nitrogen species in the gastric mucosa
[3], which may promote cancer development [4]. For example,
mice infected with H. pylori for six months have an increased
frequency of gastric mutations compared to uninfected mice [5]. In
addition, mice that are deficient for the enzyme inducible nitric
oxide synthase (iNOS) have a reduced incidence of gastric cancer
after H. pylori infection and carcinogen challenge compared to
normal mice [6]. While iNOS contributes to development of gastric
cancer, a high level of the chemokine CCL18 in gastric tumors is
associated with prolonged survival of gastric cancer patients [7].
Interestingly, iNOS is produced by classically activated/M1
macrophages whereas CCL18 production is a hallmark for
alternatively activated/M2 macrophages [8]. Taken together, these
findings suggest that macrophage polarization may have an
important role in development of H. pylori-associated gastric cancer.
M1 macrophages typically take part in the initial immune
response to invading microorganisms and promote T helper (Th) 1
immunity, whereas M2 macrophages are induced during the
resolution phase of inflammation and are involved in debris
scavenging, tissue remodeling, and promotion of Th2 immunity
[8,9]. Polarization of macrophages is directed by the microenvi-
ronment. M1 macrophages are induced by interferon-c and
microbial products such as lipopolysaccharide [9]. On the other
hand, M2 macrophages are induced by Th2- or anti-inflammatory
cytokines and growth factors, including IL-4, IL-10 and trans-
forming growth factor-b [8,9].
During H. pylori infection, macrophages are recruited to the
gastric mucosa, where they contribute to the production of pro-
inflammatory cytokines and chemokines [10,11,12,13,14,15]. In
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e15018addition, a recent study showed that liposome-mediated depletion
of macrophages reduced gastric pathology in H. pylori-infected
mice [16]. Despite this, the function of macrophages during in vivo
H. pylori infection remains relatively poorly defined. The function
of macrophages is intimately coupled to their polarization state,
which also appears to have a role in development of gastric cancer
[6,7]. Therefore, we have examined macrophage polarization in
the gastric mucosa of H. pylori-infected mice and humans. We
show that vaccination of mice against H. pylori speeds and amplifies
M1 polarization of gastric macrophages. In addition, the pre-
cancerous lesion atrophic gastritis is characterized by an enhanced
macrophage M1 polarization in humans.
Results
Increased frequency of macrophages, eosinophils and
neutrophils in the gastric mucosa after H. pylori infection
The recruitment of innate cells to the site of infection is a
prerequisite for infectious control. Not only can innate cells, such
asmacrophagesandneutrophils,participateinbacterialkilling;they
also produce inflammatory mediators, which set the stage for the
ensuing immune response. To investigate the accumulation of
innate cells in the gastric mucosa during H. pylori infection, we
infected C57BL/6 mice with the mouse-adapted H. pylori Sydney
strain 1 (SS1), and after four, eight and 26 weeks we analyzed the
gastricinflammatory infiltrateof individual mice by multi-colorflow
cytometry. The total number of lamina propria cells isolated from
the stomach did not change during the first four weeks of infection,
but at eight weeks after infection the total number of cells isolated
was doubled, and at 26 weeks of infection there was an eight-fold
increase in the total number of cells isolated compared to uninfected
mice (Fig. 1A). Among the cells being recruited to the stomach were
macrophages, eosinophils and neutrophils. Gastric macrophages
were identified as cells expressing CD11b and major histocompat-
ibility complex class II (MHC-II), but lacking expression of Gr1
(neutrophil marker), CD103 (expressed by a subset of dendritic cells
(DCs)) and sialic acid-binding immunoglobulin-like lectin (Siglec-F,
eosinophil marker) (Fig. 1B). These cells expressed the macrophage
Figure1. Accumulationof innate cells in the gastric mucosa ofH. pylori-infected mice. Mice were infected with H. pylori SS1 andafter 4, 8 and
26 weeks gastric lamina propria cells were isolated from each mouse individually and analyzed by flow cytometry. (A) Total number of cells retrieved
from the gastric lamina propria of individual mice at the indicated time points after infection. Data represent mean 6 SEM of 5–15 mice. (B) Multiple
gating strategy for identification of gastric macrophages, which were defined as Gr1
2CD11b
+CD103
2Siglec-F
2MHC-II
+ cells. These cells were sorted,
cytospun onto slides, and stained with cresyl violet. LP, lamina propria. MW, macrophage. (C) Representative dot plot showing Siglec-F
+CD11b
+
eosinophils from an infected mouse. The photomicrograph depicts sorted Siglec-F
+CD11b
+ cells prepared as described in B. (D) Representative dot plot
showing CD11b
+Gr1
+ neutrophils from an infected mouse. All CD11b
+Gr1
+ cells expressed Ly6G (histogram, thick line). The dotted line represents
staining with an isotype control. (E) Surface expression of indicated markers as well as side scatter profile of macrophages (Gr1
2CD11b
+CD103
2Siglec-
F
2MHC-II
+), eosinophils (Siglec-F
+CD11b
+) and neutrophils (CD11b
+Gr1
+). (F) Frequencies of macrophages (Gr1
2CD11b
+CD103
2Siglec-F
2MHC-II
+),
eosinophils (Siglec-F
+CD11b
+) and neutrophils (CD11b
+Gr1
+) in the gastric lamina propria at the indicated time points after H. pylori infection. Data
represent means 6 SEM of 9–19 individual mice. *, P,0.05 **, P,0.01 ***, P,0.001 compared to uninfected mice via T test.
doi:10.1371/journal.pone.0015018.g001
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confirmedasmacrophages(Fig.1B).Thefrequencyofmacrophages
in the gastric mucosa remained unchanged after four and eight
weeks of H. pylori infection (Fig. 1F). However, after 26 weeks the
frequency of gastric macrophages was increased compared to
uninfected mice (Fig. 1F).
Eosinophils were defined as CD11b
+Siglec-F
+ cells (Fig. 1C,
[17]). These cells expressed intermediate levels of F4/80 and had a
high side scatter profile when analyzed by flow cytometry (Fig. 1E).
Cresyl violet staining of sorted CD11b
+Siglec-F
+ cells confirmed
eosinophil morphology (Fig. 1C). The frequency of eosinophils in
the gastric mucosa was doubled after eight weeks and increased
further after 26 weeks of infection (Fig. 1F).
Neutrophils were defined as CD11b
+Gr1
+ cells (Fig. 1D). Since
the Gr1 antibody recognizes both the Ly6C and Ly6G epitope we
confirmed that all CD11b
+Gr1
+ cells expressed the specific
neutrophil marker Ly6G (Fig. 1D and E). The frequency of
neutrophils increased 10-fold eight weeks after infection and was
further increased after 26 weeks (Fig. 1F). Thus, during H. pylori
infection there is a sequential accumulation of neutrophils and
eosinophils, followed by macrophages in the gastric lamina propria.
Characterization of gastric DCs
To characterize gastric DCs, we first identified a population of
CD11c
+MHC-II
+ cells (Fig. 2A). When these cells were further
analyzed for expression of F4/80 and the aE integrin chain CD103,
half of the CD11c
+MHC-II
+ cells were identified as F4/80
+
macrophages (Fig. 2A). However, among the CD11c
+MHC-II
+
cells that lacked expression of F4/80, two populations of putative
DCs with differential expression of CD103 could be distinguished
(Fig. 2A). Due to the many fluorochromes required we chose to only
characterize the gastric CD103
+ DCs further, since these cells have
been implicated as important antigen presenting cells in mucosal
tissues [18]. Gastric CD103
+ DCs were easily identified by staining
for CD11c and CD103 (Fig. 2B). The gastric CD103
+ DCs
expressedhighlevelsofMHC-II,and consistedofaCD11b
lowand a
CD11b
high subset (Fig. 2C). In comparison, the gastric CD103
2
DCs were all CD11b
high (Fig. 2D). In addition, the CD103
+ DCs
lacked expression of CD8a and F4/80 (Fig. 2C). However, the
frequency of CD103
+ DCsdidnot change significantly in the gastric
mucosa after infection (Fig. 2E).
Gastric macrophages and CD103
+ DCs fail to upregulate
costimulatory molecules after H. pylori infection
In order to investigate the possible effects of H. pylori infection
on the expression of costimulatory molecules and MHC-II by
gastric macrophages and CD103
+ DCs, the expression of these
markers was analyzed by flow cytometry after four, eight and 26
weeks of infection. In the steady state, macrophages and CD103
+
DCs in the gastric lamina propria expressed similar levels of the
costimulatory molecule CD86 as well as MHC-II (Fig. 3A).
Surprisingly, the expression of CD86 and MHC-II by either
gastric macrophages or CD103
+ DCs was not increased after
infection with H. pylori relative to age-matched naı ¨ve mice
analyzed in parallel (Fig. 3B). Thus, macrophages and CD103
+
DCs in the gastric lamina propria fail to upregulate CD86 and
MHC-II after H. pylori infection, despite the ongoing inflammatory
response.
M1 polarization of gastric macrophages during H. pylori
infection
Since our results suggested that the gastric macrophages might
not be fully activated during H. pylori infection, we characterized
these cells further by investigating their M1/M2 polarization. To
determine macrophage polarization during H. pylori infection, we
used real-time PCR to measure the expression of genes associated
with M1 or M2 polarization of macrophages in the gastric tissue
[8,9]. We also measured the expression of IL-10, which can be
produced by regulatory macrophages [9]. None of the markers
analyzed were differentially expressed four weeks after H. pylori
infection relative to naı ¨ve mice (Fig. 4A). At eight weeks after
infection the expression of the M1 markers iNOS and CXCL11
was significantly increased, and these markers were further
upregulated at 26 weeks of infection (Fig. 4A). In addition, the
expression of IL-10 was upregulated at eight and 26 weeks of
infection relative to naı ¨ve mice (Fig. 4A). In contrast, the M2
markers found in inflammatory zone 1 (FIZZ1) and arginase-1
were not differentially expressed in the stomach at four, eight or 26
weeks of infection compared to naı ¨ve mice (Fig. 4A).
To identify the source of iNOS and CXCL11 in the gastric
mucosa, macrophages (CD11b
+Gr1
2Siglec-F
2MHC-II
+), eosino-
phils (CD11b
+Gr1
2Siglec-F
+MHC-II
2) and the remaining cells
after gating out macrophages and eosinophils (CD11b
2 and
CD11b
+Gr1
+) were sorted from pooled gastric lamina propria cells
Figure 2. Identification of gastric lamina propria DCs. (A) Flow
cytometric analyses of CD11c
+MHC-II
+ cells in the gastric lamina propria
of individual mice revealed two F4/80
2 DC populations with differential
expression of CD103 (lower quadrants in the F4/80 versus CD103 dot
plot). (B) Expression of CD103 and CD11c by gastric lamina propria cells.
The gate for CD103
+ DCs is indicated. Isotype, isotype-matched control
antibody for CD103. (C) Expression of MHC-II, CD8a, F4/80 and CD11b
by gated CD11c
+CD103
+ cells. Dotted lines show staining with isotype
controls. (D) Expression of CD11b by CD103
2 and CD103
+ DCs. DCs
were gated as described in A. (E) Frequency of CD103
+ DCs in the
gastric lamina propria at the indicated time points after H. pylori
infection. Data represents means 6 SEM of 7–15 individual mice. LP,
lamina propria.
doi:10.1371/journal.pone.0015018.g002
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expression of iNOS and CXCL11 in sorted cell populations from
infected mice as well as in total gastric lamina propria cells from
both naı ¨ve and infected mice was then determined by real-time
PCR. A sufficient number of sorted macrophages could not be
obtained from naı ¨ve mice for reliable analysis of mRNA
expression. Gastric macrophages expressed the highest level of
iNOS and CXCL11 compared to the other sorted cell populations
and total gastric lamina propria cells before sorting (Fig. 4C).
Taken together, these results show that gastric macrophages are
polarized to M1 during H. pylori infection.
Vaccination against H. pylori amplifies macrophage M1
polarization
Protective immunization against H. pylori is generally associated
with the rapid development of a gastric Th1 response [19]. Since
the Th1 cytokine interferon-c induces macrophage M1 polariza-
tion [9], we examined whether vaccination could influence
macrophage polarization during H. pylori infection. To this end,
mice were immunized sublingually with H. pylori lysate and cholera
toxin adjuvant, and subsequently challenged with H. pylori SS1.
This immunization regimen led to a significant reduction in
bacterial load in the stomach four weeks after challenge (Fig. 5A).
At the same time, the expression of M1 and M2 markers in the
stomach was analyzed by real-time PCR. In unimmunized mice,
only the expression of CXCL11 was significantly upregulated four
weeks after infection compared to naı ¨ve mice (Fig. 5B). In contrast,
immunized mice showed a great upregulation of both the M1
markers iNOS and CXCL11 whereas the expression of the M2
markers FIZZ1 and arginase-1 was not changed, four weeks after
challenge (Fig. 5B). The increased expression of iNOS and
CXCL11 in immunized/challenged mice was not due to the
immunization alone, since immunized but non-challenged mice
did not change the expression of any of the analyzed M1 or M2
markers compared to completely untreated mice (data not shown).
In addition, we analyzed the frequency of macrophages in the
gastric mucosa of immunized and challenged mice by flow
cytometry. Relative to infected-only mice, immunized mice had a
significantly increased frequency of gastric macrophages three
weeks after challenge (Fig. 5C). However, despite that macro-
phages were recruited to the gastric mucosa of immunized and
challenged mice, the macrophages did not upregulate the
expression of CD86 or MHC-II relative to infected-only mice
(Fig. 5D). These results show that after successful vaccination with
H. pylori lysate and cholera toxin, macrophages accumulate in the
gastric mucosa and are rapidly polarized to M1 after infection.
Augmentation of macrophage M1 polarization in human
atrophic gastritis
We next investigated the role of H. pylori infection and atrophic
gastritis for macrophage polarization in the human gastric mucosa.
To this end, the expression of human M1 (iNOS, CXCL11) and
M2 markers (CCL17, CCL18, CD206) was measured in biopsies
from antrum by real-time PCR. H. pylori-infected individuals with
uncomplicated gastritis showed a significantly elevated expression
of mRNA for both M1 (iNOS, 8-fold; CXCL11, 20-fold) and M2
markers (CCL17, 30-fold; CCL18, 70-fold, CD206, 2-fold)
compared to uninfected volunteers (Fig. 6A). However, individuals
with atrophic gastritis (4/6 had intestinal metaplasia in addition to
atrophy) expressed even higher levels of iNOS mRNA compared
to those with uncomplicated gastritis (20-fold), whereas CXCL11
and markers of M2 polarization were similarly expressed (Fig. 6A).
Indeed, the expression of iNOS was 180-fold increased in
individuals with atrophic gastritis compared to uninfected controls
(Fig. 6A), indicating an enhanced M1 polarization of gastric
macrophages in patients with atrophic gastritis.
To investigate whether the increased mRNA expression of M1
and M2 markers also translates into increased protein levels, total
proteins were extracted from antral biopsy specimens and the
concentration of iNOS and CCL18 was determined by ELISA.
Gastric biopsies from individuals with atrophic gastritis was only
available for protein extraction from one volunteer, which is
differentially indicated in Figure 6B. Half of the H. pylori-infected
individuals had detectable levels of iNOS protein in the antrum
whereas the concentration of iNOS was below the detection limit
in all uninfected individuals (Fig. 6B). The expression of iNOS
mRNA and iNOS protein was significantly correlated (R
2=0.88,
P,0.01) indicating that the mRNA analysis reflects protein
expression, even when the protein levels are low. The concentra-
tion of the M2 marker CCL18 was increased in the gastric tissue
from H. pylori-infected individuals compared to uninfected controls
(Fig. 6B). Moreover, the concentration of CCL18 protein was
significantly correlated with the expression of CCL18 mRNA
(R
2=0.754, P,0.01).
Taken together, these findings indicate the presence of both M1
and M2 macrophages in the gastric mucosa of H. pylori-infected
Figure 3. Expression of CD86 and MHC-II by gastric macro-
phages and DCs. (A) Filled histograms show expression of CD86 and
MHC-II by gastric macrophages (Gr1
2CD11b
+CD103
2Siglec-F
2MHC-II
+)
and CD103
+ DCs (CD11c
+CD103
+)f r o man a ı ¨ve mouse. Open
histograms show staining with isotype controls. (B) Expression of
CD86 and MHC-II by gastric macrophages and CD103
+ DCs at the
indicated time points after H. pylori infection as determined by flow
cytometry. The geometric mean fluorescence intensity of CD86 and
MHC-II was normalized to the level in age-matched uninfected mice.
Data represent mean 6 SEM of 10–16 individual mice.
doi:10.1371/journal.pone.0015018.g003
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strong amplification of iNOS expression in the gastric mucosa,
indicating an enhanced M1 polarization of macrophages.
Discussion
In this study, we have investigated the polarization of gastric
macrophages during chronic H. pylori infection. We show that H.
pylori-infected individuals express mRNA in the gastric mucosa
indicative of a mixed M1/M2 polarization of macrophages, and
this was further confirmed at the protein level. However, in H.
pylori-induced atrophic gastritis there was a marked elevation in the
expression of iNOS compared to uncomplicated gastritis. Atrophic
gastritis confers an increased risk of developing gastric cancer
relative to uncomplicated H. pylori-associated gastritis [20]. The
increased expression of iNOS in atrophic gastritis may contribute
Figure 4. M1 polarization of gastric macrophages after H. pylori infection. (A) Expression of genes associated with macrophage polarization
in the gastric mucosa of naı ¨ve and infected mice was determined by real-time PCR. Symbols represent individual mice, and horizontal bars indicate
the medians. *, P,0.05 **, P,0.01 compared to the expression level in uninfected mice via Mann-Whitney U test. (B) Sorting of gastric lamina propria
macrophages (Gate R1 and R2, CD11b
+Gr1
2Siglec-F
2MHC-II
+), eosinophils (Gate R1 and R3, CD11b
+Gr1
2Siglec-F
+MHC-II
2) and remaining cells after
gating out macrophages and eosinophils (Gate R4, CD11b
2 and CD11b
+Gr1
+) from pooled (n=3) mice infected for 26 weeks. Contour plots show
expression of CD11b versus Gr1 on gated live cells, and expression of Siglec-F versus MHC-II on gated CD11b
+Gr1
2 cells before and after sorting. The
gates for sorting (R1–R4) are shown in the top contour plots. Numbers by gates depict cell frequencies. Note that in this experiment the few CD103
+
DCs that fall into the macrophage gate (,2%, see Fig. 1A) were not gated out. (C) Real-time PCR analysis of iNOS and CXCL11 mRNA expression by
total gastric lamina propria cells pooled from naı ¨ve (n=3) or infected (n=3, 26 weeks) mice before sorting as well as expression by sorted
macrophages (Gate R1 and R2, CD11b
+Gr1
2Siglec-F
2MHC-II
+,9 610
5 cells), eosinophils (Gate R1 and R3, CD11b
+Gr1
2Siglec-F
+MHC-II
2,6 610
5 cells)
and remaining cells after gating out macrophages and eosinophils (Gate R4, CD11b
2 and CD11b
+Gr1
+,3 610
6 cells) from infected mice. Bars are the
mean of two to three replicates, and dots represent each replicate. Undet., undetected. MW, macrophages. Eos, eosinophils.
doi:10.1371/journal.pone.0015018.g004
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species, which can promote carcinogenesis by induction of DNA
damage, disruption of DNA repair, post-translational modification
of proteins, and p53 mutations [4]. Indeed, iNOS-deficient mice
have a reduced incidence of gastric adenocarcinoma after H. pylori
infection and challenge with a chemical carcinogen compared to
normal mice [6]. Also, polymorphisms in the promoter region of
iNOS, leading to a higher transcriptional activity, correlate with a
higher incidence of the intestinal type of gastric cancer in Japanese
women [21].
In contrast to human H. pylori infection, SS1-infected C57BL/6
mice showed a gene expression profile in the gastric mucosa
indicative of macrophage M1 polarization. Gene expression
analysis of sorted macrophages isolated from the gastric mucosa
of infected mice confirmed that expression of the M1 markers
iNOS and CXCL11 was enriched in the sorted macrophage
population. Furthermore, the M1 polarization of gastric macro-
phages was substantially accelerated by prior vaccination. Already
four weeks after challenge, immunized mice upregulated the
expression of iNOS and CXCL11 to a similar level as that seen
after 26 weeks in infected-only mice. Studies of iNOS-deficient
mice have shown that iNOS promotes development of atrophy
and cancer in the gastric mucosa during Helicobacter infection
[6,22]. Moreover, clearance of H. pylori after vaccination occurs
independently of iNOS [23]. Thus, iNOS appears to contribute to
host pathology rather than protection during infection with H.
pylori. Therefore, if the enhanced production of iNOS in the gastric
mucosa is maintained after vaccination, it may be an unwanted
side effect that can augment the severity of H. pylori-induced
inflammation and malignancy, unless sterile immunity is achieved.
However, the relative contribution of iNOS to host pathology
versus protection during different stages of H. pylori infection
warrants further investigation.
We observed a sequentialrecruitment of innate cells to the gastric
mucosa of SS1-infected mice, with the macrophages accumulating
rather late during the course of infection (26 weeks). In contrast, the
frequencies of gastric neutrophils and eosinophils in the gastric
mucosa increased eight weeks after infection and remained elevated
at 26 weeks. The accumulation of macrophages occurred much
faster in vaccinated mice, in which case the frequency of gastric
macrophages was increased already three weeks after challenge.
Previously, neutrophils have been shown to be recruited to the
gastric mucosa of SS1-infected mice in two phases, one early phase
peaking 1–2 daysafterinfectionand one late phasebeginningat2–3
weeks after infection [24]. A recruitment pattern, similar to that of
neutrophils, was also described for gastric macrophages [24].
However, the macrophages were defined as CD11b
+Gr1
2 cells
[24], a cell population that in our hands primarily consists of
Figure 5. M1 polarization of gastric macrophages in immunized mice following challenge with H. pylori. Mice were immunized with H.
pylori lysate and cholera toxin and challenged with H. pylori SS1 (I/C: immunized/challenged). A second group of mice was infected with SS1 without
prior immunization (U/C: unimmunized/challenged) and a third group was left untreated (U/NC: unimmunized/non-challenged). (A) Number of
bacteria cultured from the stomach of U/C and I/C mice four weeks after challenge. Horizontal bars indicate the median. *, P,0.05 via Mann-Whitney
U test. (B) Four weeks after challenge the expression of genes associated with macrophage polarization was determined in the gastric mucosa of the
mice shown in A by real-time PCR. Symbols represent individual mice, and horizontal bars indicate the medians. **, P,0.01 compared to the
expression level in U/NC mice via Mann-Whitney U test. (C) In separate experiments, the frequency of gastric macrophages (Gr1
2CD11b
+CD103
2Si-
glec-F
2MHC-II
+) in U/C and I/C mice was determined by flow cytometry three weeks after H. pylori infection. Each symbol represents individual mice,
and horizontal bars indicate the mean. ***, P,0.001 via T test. (D) Flow cytometric analysis of CD86 and MHC-II expression by gastric macrophages
(Gr1
2CD11b
+CD103
2Siglec-F
2MHC-II
+) from the U/C and I/C mice shown in C. The geometric mean fluorescence intensity was normalized to the
level in U/C mice. Data are presented as mean 6 SEM.
doi:10.1371/journal.pone.0015018.g005
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CD11b
+F4/80
+ cells, and observed an early peak in macrophage
number in the gastric mucosa 1–2 days after infection with H. pylori
[15]. In addition, the number of macrophages was increased again
at 60 and 120 days after infection relative to naı ¨ve mice [15]. We
extend these results by showing that the recruitment of these innate
cell populations is maintained up until 26 weeks after infection. In
addition, we describe the accumulation of eosinophils in the gastric
mucosa, a cell population that by far outnumber the gastric
macrophagesandneutrophils(Fig.1).Indeed,theroleofeosinophils
in H. pylori-induced gastritis should be investigated further.
Eosinophils and macrophages share expression of several markers,
including CD11b and F4/80 (Fig. 1, [25]). Therefore, multiple
markers need to be analyzed simultaneously in order to distinguish
these innate cell populations.
We were able to identify two populations of DCs in the gastric
mucosa of mice. Both subsets expressed high levels of CD11c and
MHC-II, lacked expression of the macrophage marker F4/80, but
differed with regards to expression of CD103. The frequency of
gastric CD103
+ DCs did not change after four, eight or 26 weeks of
H. pylori infection. In contrast to our study, a recent study by Kao et
al. could not detect CD103
+ DCs in the gastric mucosaof uninfected
mice [26]. Rather, the CD103
+ DCs emerged 24 hr after H. pylori
infection. Since the times of analysis differ between that study and
our experiments, it is hard to directly compare the results.
Despite that M1 macrophages typically upregulate MHC-II and
costimulatory molecules, we could not detect an increased
expression of MHC-II or CD86 on gastric macrophages or
CD103
+ DCs from either unimmunized or immunized mice after
infection. In contrast, in vitro incubation of H. pylori with human
Figure 6. Increased M1 macrophage polarization in human atrophic gastritis. (A) The expression of genes associated with human M1
(iNOS, CXCL11) or M2 (CCL17, CCL18, CD206) macrophage polarization was determined in the gastric mucosa of uninfected and H. pylori-infected
individuals with uncomplicated or atrophic gastritis by real-time PCR. Symbols represent individual values and horizontal bars indicate the medians.
(B) Concentration of CCL18 and iNOS in protein extracts of gastric biopsy specimens from uninfected and H. pylori-infected individuals. Filled circles
represent individuals with uncomplicated H. pylori-associated gastritis and the triangle represents a single individual with atrophic gastritis.
Horizontal bars indicate the medians. *, P,0.05 ***, P,0.001 via Mann-Whitney U test.
doi:10.1371/journal.pone.0015018.g006
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murine bone marrow-derived DCs [32,33], or human primary
gastric DCs [34], induces upregulation of costimulatory molecules
and MHC-II. Therefore the failure to upregulate MHC-II and
CD86 on gastric macrophages and CD103
+ DCs in chronic H.
pylori infection may be caused by the inflammatory milieu and not
by the bacteria per se. Indeed, the interaction between DCs and
H. pylori in vitro does not necessarily reflect what happens in vivo,
where the local microenvironment at the site of antigen acquisition
and antigen presentation as well as the DC subset involved in
antigen presentation of H. pylori, will influence the response. For
example, regulatory T cells, which are prevalent in the H. pylori-
infected gastric mucosa [35,36], can prevent the upregulation of
costimulatory molecules and MHC-II on DCs [37]. In addition,
IL-10 can prevent the upregulation of costimulatory molecules and
MHC-II on macrophages and DCs [38].
During acute inflammatory responses, macrophages are typi-
cally polarized to M1 and exert potent anti-microbial effects. For
example, infection with Salmonella typhimurium or Listeria monocyto-
genes induces M1 polarization of macrophages, which is required
for control of the infection [39]. Resolution of inflammation is
characterized by a shift in macrophage polarization to M2, which
promotes tissue healing. Tuberculosis patients display an increased
production of Th2 cytokines as the infection progresses [40,41],
which can induce M2 polarization of macrophages. In mice, M1
polarization of macrophages constitutes the early response to
Mycobacterium tuberculosis, whereas alveolar macrophages are
polarized to M2 during late stage infection [42]. However, the
shift in macrophage polarization induced by chronic infections
often results in a reduced capacity of the macrophages to kill the
invading bacteria [39,43]. On the other hand, chronic inflamma-
tion with persistent M1 macrophage polarization is associated with
an increased risk of cancer development [4].
Do macrophages contribute to host defense against H. pylori?
Unlike neutrophils, macrophages are not frequently seen in the
gastric lumen after translocation across the epithelium [44]. Since H.
pylori preferentially reside in the gastric mucus layer or are attached to
gastric epithelial cells, macrophages may not come in direct contact
with whole bacteria. Indeed, depletion of macrophages by drug-
loaded liposomes had no effect on H. pylori colonization [16],
suggesting that macrophages may not directly contribute to host
defense against H. pylori. In contrast, macrophages may promote
gastric pathology. For example, liposome-mediated depletion of
macrophages ameliorated the gastritis induced by H. pylori infection
[16]. In addition, selective deletion of I-kB-kinase b in myeloid cells,
which prevents activation of NF-kB in these cells, inhibited the
development of gastric atrophy after H. felis infection [45]. Thus,
macrophages donotappear to contribute to Helicobacter clearance, but
may rather promote gastric pathology.
In conclusion, this study shows that vaccination of mice against
H. pylori amplifies M1 polarization of gastric macrophages. A
similar phenomenon is seen in human atrophic gastritis where the
mixed M1/M2 polarization present in uncomplicated gastritis is
replaced by an M1-dominated polarization. This may induce a
tumor-promoting inflammation, and shifting macrophage polar-
ization from M1 to M2 could therefore represent a therapeutic
target in chronic H. pylori infection.
Materials and Methods
Ethics statement
The study was approved by the government animal ethics
committee (Go ¨teborgs djurfo ¨rso ¨ksetiska na ¨mnd, 328/2008 and
254/2009). The regional human ethics committee of Va ¨straGo ¨taland
County in Sweden (706/03 and 85/06) approved the study, and
written informed consent was obtained from all participants. This is
the only authority giving ethical permission for research on humans in
Sweden, and it is not directly associated to hospitals or universities.
Mice
Female C57BL/6 mice were purchased from Charles River
Laboratories (Sulzfeld, Germany), or in the case of the vaccination
experiments from Taconic (Ejby, Denmark). Mice were infected at
an age of 8–12 weeks.
Bacteria and infection of mice
H. pylori SS1 was grown on Columbia ISO agar plates for 2 days
at 37uC, after which they were transferred to Brucella broth
supplemented with 5% fetal calf serum (FCS) and antibiotics
(Vancomycin, 10 mg/ml; Polymyxin B, 20 U/ml; Trimethoprim,
5 mg/ml) and incubated shaking over night at 37uC under
microaerophilic conditions. Before infection, the motility of the
bacteria was confirmed by microscopy. The concentration of
bacteria was estimated spectrophotometrically. Mice received
3610
8 colony-forming units of SS1 intragastrically.
Sublingual immunization
Mice were given four 10 ml doses of 500 mg H. pylori lysate
(prepared from strain Hel305 as previously described [46])
combined with 10 mg cholera toxin (List Biological Laboratories
Inc., Madison, NJ) sublingually at 1-week intervals [47,48]. Two
weeks after the last immunization, the mice were challenged
intragastrically with 3610
8 colony-forming units of H. pylori SS1.
Assessment of bacterial colonization
For quantitative assessment of bacterial colonization in
immunization experiments, one half of the stomach was gently
washed with PBS and homogenized using an Ultra Turrax
homogenizer (IKA Laboratory Technology, Staufen, Germany).
Serial dilutions of the homogenate were plated on Skirrow agar
plates. When gastric lamina propria cells were isolated from the
whole stomach a quantitative estimation of the gastric bacterial
load could not be performed. In this case, the stomach, which was
cut along the greater curvature and washed in PBS, was gently
streaked on Skirrow agar plates. The presence of H. pylori colonies
was confirmed by a urease test. In this way we could confirm H.
pylori colonization and still use the whole stomach for cell isolation.
Isolation of gastric lamina propria cells
The glandular stomach was cut into 5 mm pieces and incubated
a total of three times with 2 mM EDTA in Hanks’ balanced salt
solution (HBSS) (Invitrogen) supplemented with 2% FCS for
15 min at 37uC, followed by vigorous shaking for 15 s and
filtration to remove epithelial cells. The remaining tissue was
incubated with 100 U/ml collagenase type VIII (Sigma-Aldrich,
St Louis, MO) in RPMI 1640 containing 10% FCS and 10 mM
HEPES for 60 min at 37uC. The released lamina propria cells
were collected by filtration through a nylon mesh, and the
remaining tissue was subjected to a second round of collagenase
digestion. Leukocytes were further enriched on a 40:70 Percoll
gradient after centrifugation at 600 g for 20 min.
Flow cytometry
To block unspecific binding, single-cell suspensions were
incubated with anti-Fcc receptor II/III monoclonal antibody
(2.4G2, own production). Then cells were stained with the
following monoclonal antibodies: anti-CD11b-PE or -allophyco-
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2440), CD103 biotinylated (M290), Ly6G-FITC (1A8), CD11c-
FITC (HL3), CD86-PE (GL1), MHC-II-PE (M5/114.15.2), and
CD8a-allophycocyanin (53-6.7) (BD Biosciences, San Jose, CA),
MHC-II-AlexaFluor 700 (M5/114.15.2) (Biolegend, San Diego,
CA), and F4/80-PE (CI:A3-1) (Caltag Laboratories, Buckingham,
UK). 7-Aminoactinomycin D (7AAD, Sigma-Aldrich) was includ-
ed for dead cell exclusion. For biotinylated antibodies streptavidin-
allophycocyanin was used as a second-step reagent (BD Biosci-
ences). Samples were acquired on an LSR-II flow cytometer (BD
Biosciences) and analyzed using FlowJo software (Tree star,
Ashland, OR).
Cell sorting
For morphological studies, gastric eosinophils (7AAD
2,
CD11b
+, Siglec-F
+) and macrophages (7AAD
2, CD11b
+, Gr1
2,
CD103
2, Siglec-F
2, MHC-II
+) were sorted with a FACSAria (BD
Biosciences). The purity of sorted cells was .96%. Cytospin
preparations of purified eosinophils and macrophages were stained
with cresyl violet.
For gene expression analysis, gastric macrophages (7AAD
2,
CD11b
+, Gr1
2, Siglec-F
2, MHC-II
+;9 610
5 cells), eosinophils
(7AAD
2, CD11b
+, Gr1
2, Siglec-F
+, MHC-II
2;6 610
5 cells), and
the remaining cells after gating out macrophages and eosinophils
(7AAD
2, CD11b
2 and 7AAD
2, CD11b
+, Gr1
+;3 610
6 cells) were
sorted to .92% purity. Total RNA was isolated using the Qiagen
RNeasy mini kit and transcribed into complementary DNA using
the Omniscript kit (Qiagen). Real-time PCR was performed as
described below.
Volunteers and specimen collection
Ten H. pylori-infected volunteers and nine uninfected individuals
were recruited among healthy blood donors at Sahlgrenska
University hospital after serological screening. In addition, the
study included five H. pylori-infected patients with atrophic gastritis
and five uninfected individuals, who underwent endoscopy at
Sahlgrenska University hospital because of abdominal complaints.
H. pylori infection was confirmed or excluded by culture on
Skirrow agar plates as well as by serology [49] and pathology
reports. Three antrum biopsy specimens were put in RNA Later
(Ambion, Austin, TX) and then stored at 270uC until RNA
isolation. An additional three antral biopsies were snap frozen in
liquid nitrogen and stored at 270uC for subsequent protein
extraction. One biopsy specimen from antrum (all individuals) and
corpus (volunteers recruited at the hospital) was examined by an
experienced histopathologist, and the grade of gastritis, including
presence of atrophic gastritis and intestinal metaplasia, was
determined according to the updated Sydney system [50]. In
total, the study included nine individuals with uncomplicated H.
pylori-associated gastritis (mean age 47 years, range 32–67 years,
five females), six H. pylori-infected individuals with atrophic
gastritis (mean age 74 years, range 63–81 years, three females)
and 14 uninfected individuals (mean age 49 years, range 27–75
years, seven females).
Real-time RT-PCR
Human antral biopsies as well as longitudinal strips from the
greater curvature of the mouse stomach were homogenized using a
TissueLyserII (Qiagen, Valencia, CA). Total RNA was extracted
using the Qiagen RNeasy mini kit and transcribed into
complementary DNA using Oligo(dT) and the Omniscript kit
(Qiagen). Real-time PCR was performed with TaqMan gene
expression assays and the TaqMan Universal Master Mix from
Applied Biosystems (Foster City, CA). Reactions were run in
duplicate using standard amplification conditions for the 7500
real-timePCRsystem (Applied Biosystems).Relative expressionlevels
were determined by the DDCt method using hypoxanthine
phosphoribosyltransferase 1 (HPRT1) and b-actin as reference genes
for human and mouse expression assays, respectively. Data are
e x p r e s s e da sc h a n g ei nm R N Ae x p r e s s i o nr e l a t i v et oac a l i b r a t o r
sample. For human samples, a tonsil specimen was used as calibrator,
whereas a gastric sample from one of the naı ¨ve mice was used as
calibrator in mouse assays. The following primer sets from Applied
Biosystems were used for human genes: HPRT1 (Hs99999909-
m1), CCL17 (Hs00171074-m1), CCL18 (Hs00268113-m1),
CD206 (Hs00267207-m1), iNOS (Hs00167257-m1), CXCL11
(Hs00171138-m1). The primer sets used for mouse genes were as
follows: b-actin (Mm01205647-g1), FIZZ1 (Mm00445109-m1),
arginase-1 (Mm00475988-m1), IL-10 (Mm01288386-m1), iNOS
(Mm01309897-m1), CXCL11 (Mm00444662-m1).
Detection of CCL18 and iNOS in human gastric protein
extracts
Three antral biopsies from each individual were incubated in
600 ml PBS containing saponin, soybean trypsin inhibitor,
Pefabloc, and bovine serum albumin overnight at 4uCa s
previously described [51]. The concentration of CCL18 and
iNOS in the protein extracts was determined using a Duoset
ELISA for CCL18 (R&D systems, Abingdon, United Kingdom)
and a Quantikine ELISA for iNOS (R&D systems) according to
the manufacturer’s instructions. The extracts were desalted on
Zeba Micro Desalt spin columns (Thermo Scientific, Rockford, IL)
and total protein concentrations were measured using the BCA
protein assay (Thermo Scientific). The concentration of CCL18
and iNOS was normalized to the total protein content of the
extracts.
Statistics
Statistical analysis was performed using SPSS 17.0 software.
Means were compared using an independent samples T test and
Levene’s test for equality of variances. Non-parametric data was
analyzed using a two-tailed Mann-Whitney U test. Correlation
was evaluated using a two-tailed Pearson test. Values of P,0.05
were considered significant.
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